Cargando…
肿瘤突变负荷对肺癌免疫治疗疗效的预测价值
The morbidity and mortality of lung cancer is the first in the world, immunotherapy has become a important treatment strategy in addition to chemotherapy, radiotherapy and targeted therapy. In recent years, the US Food and Drug Administration (FDA) has successively approved immunological checkpoint...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580077/ https://www.ncbi.nlm.nih.gov/pubmed/31196372 http://dx.doi.org/10.3779/j.issn.1009-3419.2019.06.08 |